Director of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Levy Noah G., buys 56,490 shares worth $205,912
According to Merrimack Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 16 04:05 PM, company Director, Levy Noah G. disclosed buying 56,490 shares at a cost of $3.65. At the time of this transaction (Nov 12), this trade was worth $205,912 in total. As of Nov 12, Levy Noah G. now owns 839,005 shares in total worth about $3,104,318.5.
For the last few recent trades made by Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director, Levy Noah G., we have the following information:
- SEC Form 4 filing: Aug 13: Bought 608 shares at the rate of $3.50 per share. Total worth of this trade was $2,128. Total number of shares owned as of Aug 13 were 806,071
- SEC Form 4 filing: Aug 11: Bought 14,042 shares at the rate of $3.45 per share. Total worth of this trade was $48,480. Total number of shares owned as of Aug 11 were 804,551
- SEC Form 4 filing: Aug 12: Bought 2,000 shares at the rate of $3.49 per share. Total worth of this trade was $6,986. Total number of shares owned as of Aug 12 were 805,717
Posted by
George Daniels
on Monday November 16 2020, 5:29 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
